Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...